#USA #New York #Class Action #Levi & Korsinsky #LifeMD

LifeMD Class Action Lawsuit Alert

On October 1, 2025, Levi & Korsinsky, LLP announced a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD), aimed at investors who may have suffered losses due to alleged securities fraud.

Overview of the Case

The class action lawsuit arises from events between May 7, 2025, and August 5, 2025. During this time, investors claim that LifeMD provided misleading information about its business practices and competitive position, which ultimately misled the market regarding its true financial status. The firm alleges that LifeMD not only exaggerated its market position but also failed to accurately consider rising costs associated with acquiring new customers in its RexMD segment, including expenses linked to obesity drug sales such as Wegovy and Zepbound.

Allegations and Impact on Investors

The key points of the lawsuit include:
1. Material Overstatements: It is alleged that LifeMD overstated its competitive advantages in the market, significantly impacting investor decisions and leading to losses when the true financials were revealed.
2. Reckless Guidance: Claims suggest that the company irresponsibly raised guidance for 2025 without adequately accounting for escalating customer acquisition costs, indicating a lack of proper financial oversight.
3. Misleading Statements: The defendants purportedly made statements about LifeMD's business plans and expectations that were not merely wrong, but fundamentally flawed, lacking any reasonable foundation.

These contentious points suggest a pattern of behavior that could have potential legal ramifications and serious financial consequences for affected shareholders.

Next Steps for Investors

Investors who believe they were harmed during the relevant period have until October 25, 2025, to request that the court appoint them as lead plaintiffs. Importantly, engaging in the process does not obligate individuals to be lead plaintiffs to pursue recovery from potential damages incurred.

No Financial Obligation

The firm assures that class members can pursue compensation without any out-of-pocket expenses or fees related to these claims. This promise underscores the commitment of Levi & Korsinsky to protect shareholders and facilitate their claims without undue financial burden.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has built a strong reputation over the last two decades, securing hundreds of millions of dollars for investors in similar situations. The firm specializes in complex securities litigation, boasting a team of over 70 skilled professionals dedicated to advocating for shareholders’ rights. Consequently, for seven consecutive years, they have been recognized as one of the top firms representing aggrieved shareholders in the United States by ISS Securities Class Action Services.

Contact Information

Investors seeking further information or wishing to participate should consider contacting Joseph E. Levi, Esq. by email at email protected] or by phone at (212) 363-7500. For additional details, you can also visit their [website.

In conclusion, the ongoing legal action against LifeMD is a significant issue for investors, and taking timely steps can help ensure proper representation and potential recovery of losses. As this case continues to develop, affected shareholders should stay informed and consider their options carefully.